These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
567 related items for PubMed ID: 16873892
1. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Andersen AN, Devroey P, Arce JC. Hum Reprod; 2006 Dec; 21(12):3217-27. PubMed ID: 16873892 [Abstract] [Full Text] [Related]
2. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Smitz J, Andersen AN, Devroey P, Arce JC, MERIT Group. Hum Reprod; 2007 Mar; 22(3):676-87. PubMed ID: 17110397 [Abstract] [Full Text] [Related]
3. Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Ziebe S, Lundin K, Janssens R, Helmgaard L, Arce JC, MERIT (Menotrophin vs Recombinant FSH in vitro Fertilisation Trial) Group. Hum Reprod; 2007 Sep; 22(9):2404-13. PubMed ID: 17640944 [Abstract] [Full Text] [Related]
5. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing their first treatment cycle of IVF or ICSI. Bjercke S, Tanbo T, Abyholm T, Omland A, Opøien HK, Fedorcsak P. Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1053-60. PubMed ID: 20602599 [Abstract] [Full Text] [Related]
6. Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial. Ye H, Huang G, Pei L, Zeng P, Luo X. Gynecol Endocrinol; 2012 Jul; 28(7):540-4. PubMed ID: 22390186 [Abstract] [Full Text] [Related]
7. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques. Cheon KW, Byun HK, Yang KM, Song IO, Choi KH, Yoo KJ. J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565 [Abstract] [Full Text] [Related]
8. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation]. Ye H, Huang GN, Cao YX, Zhong Y, Huang YH, Zhu GJ, Zhou LM, Chen ZJ, Shi JZ, Zeng Y, Weng N, Huang XF, Yang J, Zhu YM, Li YP, Yi D, Zhuang GL. Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561 [Abstract] [Full Text] [Related]
13. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Barrenetxea G, Agirregoikoa JA, Jiménez MR, de Larruzea AL, Ganzabal T, Carbonero K. Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989 [Abstract] [Full Text] [Related]
14. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial. Drakopoulos P, Vuong TNL, Ho NAV, Vaiarelli A, Ho MT, Blockeel C, Camus M, Lam AT, van de Vijver A, Humaidan P, Tournaye H, Polyzos NP. Hum Reprod; 2017 Nov 01; 32(11):2225-2233. PubMed ID: 29040589 [Abstract] [Full Text] [Related]
16. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT. Moro F, Scarinci E, Palla C, Romani F, Familiari A, Tropea A, Leoncini E, Lanzone A, Apa R. Hum Reprod; 2015 Jan 01; 30(1):179-85. PubMed ID: 25398971 [Abstract] [Full Text] [Related]